Early liver dysfunction in schistosomiasis

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 233-240

  Camacho Lobato, Luciana ^a   Borges, Durval Rosa ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Liver function; Plasminogen activator tissue type; Prothrombin fragment(1+2); Schistosomiasis; Thrombin antithrombin complex

Indexed keywords

ALBUMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR; PLASMINOGEN ACTIVATOR; PREALBUMIN; PROTEIN C; PROTHROMBIN; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; ECHOGRAPHY; HEMOSTASIS; HUMAN; LIVER DYSFUNCTION; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 0032146968     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80008-1     Document Type: Article

References (50)

1. Borges DR. Thesis. 1971;Escola Paulista de Medicina, São Paulo. Estudo da hemostasia na esquistossomose mansoni: formas hepatointestinal e hepatoesplênica.
2. Omran SA, El-Bassiouni NE, Hussein NA, Akl MM, Hussein AT, Mohamed AA. Disseminated intravascular coagulation in endemic hepatosplenic schistosomiasis. Haemostasis. 25:1995;218-228.
3. El-Bassiouni NE, El Bassiouny AE, El-Khayat HR, Akl MM, Omran SA. Hyperfibrinolysis in hepatosplenic schistosomiasis. J Clin Pathol. 49:1996;990-993.
4. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis: diagnostic interest. Dig Dis Sci. 39:1994;2426-2432.
5. Teran JC, Bashour EN, Sondhi SS, Mullen KD. Validation of a discriminant score for the diagnosis of cirrhosis in patients with chronic hepatitis [abstract]. Gastroenterology. 108:1995;1185.
6. Becker U, Deis A, Sorensen TIA, Gronbaek M, Borch-Johnsen K, Müller CF, et al. Prediction of the risk of liver disease by alcohol intake, sex and age: a prospective population study. Hepatology. 23:1996;1025-1029.
7. The use of diagnostic ultrasound in schistosomiasis - attempts at standardization of methodology. Acta Tropica. 51:1992;45-63.
8. Iversen LH, Thorlacius-Ussing O. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma. Thromb Res. 81:1996;253-261.
9. Camacho-Lobato L, Borges DR. Plasma hemostatic proteins in the hepatointestinal form of schistosomiasis mansoni. Clin Appl Thrombosis/Hemostasis. 2:1996;276-278.
10. Bauer KA. Laboratory markers of coagulation activation. Arch Pathol Lab Med. 117:1993;71-77.
11. Stein PC, Von Lichtenberg F. Schistosoma mansoni: topochemical features of cercaria, schistosomula and adults. Exp Parasitol. 33:1973;499-514.
12. Saito H. Evasion of host hemostasis by parasites: modulation of blood coagulation and platelet function. J Lab Clin Med. 117:1991;341-342.
13. Olgivie BM, Wilson RJ. Evasion of the immune response by parasites. Br Med Bull. 32:1976;177-181.
14. Tsang VCW, Hubbard WJ, Damian RT. Coagulation factor XIIa (activated Hageman factor) inhibitor from adult Schistosoma mansoni. Am J Trop Med Hyg. 26:1977;243-247.
15. Tsang VCW, Damian RT. Demonstration and mode of action of an inhibitor for activated Hageman factor (fator XIIa) of the intrinsic blood coagulation pathway from Schistosoma mansoni. Blood. 49:1977;619-633.
16. Foster CB, Flaningan TP, Destigter KK, Blanton R, Dumenco LL, Gallagher C, et al. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni. J Lab Clin Med. 120:1992;735-739.
17. Ngaiza JR, Doenhoff MJ. Schistosoma mansoni-induced thrombocytopenia in mice. Trans R Soc Trop Med Hyg. 81:1987;655-656.
18. Vasconcelos EG, Nascimento PS, Meirelles MNL, Verjovski-Almeida S, Ferreira ST. Characterization and localization of an ATP-diphosphohydrolase on the external surface of the tegument of Schistosoma mansoni. Mol Biochem Parasitol. 58:1993;205-214.
19. Horta MFM, Ramalho-Pinto FJ. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro. J Exp Med. 174:1991;1399-1406.
20. Robertson NP, Cain GD. Isolation and characterization of glycosaminoglycans from Schistosoma mansoni. Comp Biochem Physiol. 82B:1985;299-306.
21. Maizels RM, Bundy DAP, Selkirk ME, Smith DF, Anderson RM. Immunological modulation and evasion by helminth parasites in human populations. Nature. 365:1993;797-805.
22. Chiang C-P, Caulfield JP. Human lipoprotein binding to schistosomula of Schistosoma mansoni: displacement by polyanions, parasite antigen masking of persistence in young larvae. Am J Pathol. 135:1989;1015-1024.
23. Bennett MW, Caulfield JP. Specific binding of human low-density lipoprotein to the surface of schistosomula of Schistosoma mansoni and ingestion by the parasite. Am J Pathol. 138:1991;1173-1182.
24. Smith JH, Von Lichtenberg F. Observation on the ultrastructure of the tegument of Schistosoma mansoni. Am J Trop Med Hyg. 23:1974;71-77.
25. Guerra CCC, Silva MP, Borges DR, Vilela MP. Coagulação intravascular disseminada crônica na esquistossomose mansônica hepatoesplênica. Rev Bras Pesq Méd Biol. 5:1972;34-41.
26. Violi F, Ferro D, Basili S, Cimminielo C, Saliola M, Vezza E, et al. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. Hepatology. 22:1995;96-100.
27. Nagaoka MR, Kouyoumdjian M, Borges DR. Plasma kallikrein and tissue-type plasminogen activator compete for a common pathway into the liver. Immunopharmacology. 32:1996;88-90.
28. Omran SA, Madkour BA, Essawy FM, Toima SM, El-Kaliouby AH, Shams El-Din AA. The pathogenesis of accelerated fibronolysis in hepatosplenic schistosomiasis. Blood Coagul Fibrinolysis. 3:1992;819-822.
29. Okabe K, Kato I, Sato S, Kashiwabara T, Furuta S, Sato H, et al. Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases. Gastroenterol Jpn. 27:1992;61-68.
30. Maekawa H, Yoshikawa Y, Toda G, Oka H. Evaluation of plasma tissue plasminogen activator (t-PA) levels in patients with liver diseases [abstract]. Nippon Shokakibyo Gakkai Zasshi. 87:1990;62-68.
31. Leiper K, Croll A, Booth NA, Moore NR, Sinclair T, Bennett B. Tissue plasminogen activator, plasminogen activator inhibitors and activator-inhibitor complex in liver disease. J Clin Pathol. 47:1994;214-217.
32. Lasierra J, Barrao F, Ceña G, Aza MJ, Morandeira MJ, Barrao ME, et al. Changes of the fibrinolytic system in liver dysfunction: role of portal hypertension. Thromb Res. 67:1992;15-21.
33. Barone B, Guerra CCC, Borges BR, Oliveira E, Silva MP, Vilela MP, et al. Hipocoagubildade - uma nova indicação para esplenectomia na esquistossomose mansônica hepatoesplênica. Rev Ass Med Brasil. 19:1973;393-396.
34. Symmers W. Note on a new form of cirrhosis due to the presence of the ova of Bilharzia haematobia. J Pathol Bact. 9:1904;237.
35. Bogliolo L. The anatomical picture of the liver in hepatosplenic schistosomiasis mansoni. Ann Trop Med Parasit. 51:1956;1-14.
36. Da Silva LC, Carrilho FJ. Hepatosplenic schistosomiasis: pathophysiology and treatment. Gastroenterol. Clin N Am. 21:1992;163-177.
37. Grimaud JA, Borojevic R. Chronic human schistosomiasis mansoni: pathology of the Disse's space. Lab Invest. 36:1977;268-273.
38. Canto AL, Sesso A, Brito T. Human chronic mansonian schistosomiasis - cell proliferation and fibre formation in the hepatic sinusoidal wall: a morphometric, light and electron-microscopy study. J Pathol. 123:1977;35-44.
39. Yang Z. Liver microcirculative disturbance in schistosomiasis portal hypertension [abstract]. Chung Hua I Hsueh Tsa Chih. 73:1993;72-74.
40. Yang Z, Wang G, Cai H. Immunohistochemical study of epidermal growth factor in liver of mice infected with Schistosoma japonicum [abstract]. Chung Hua Wai Ko Tsa Chih. 33:1995;127-128.
41. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology. 44:1963;239-242.
42. Villeneuve J-P, Dagenais M, Huet P-M, Roy A, Lapointe R, Marleau D. The hepatic microciruclation in the isolated perfused human liver. Hepatology. 23:1996;24-31.
43. Branch RA, James JA, Read AE. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease. Clin Pharmacol Ther. 20:1976;81-89.
44. Kawasaki S, Imamura H, Bandai Y, Sanjo K, Idezuki Y. Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology. 102:1992;1351-1355.
45. Cerri GG, Alves VAF, Magalhães A. Hepatosplenic schistosomiasis mansoni: ultrasound manifestations. Radiology. 153:1984;777-780.
46. Gray H. 29th ed. Anatomia. 1977;Guanabara Koogan, Rio de Janeiro.
47. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood. 87:1996;567-573.
48. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 86:1995;419-431.
49. Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-MPL ligand. Nature. 369:1994;533-538.
50. Martins RD, Borges DR. Ethanol challenge in non-alcoholic patients with schistosomiasis. J Clin Pathol. 46:1993;250-253.